Drag a card by its title · ⚙ to size, swap or remove

The company

IRIDEX Corporation

IRIX · Nasdaq

Health CareMedical DevicesNot moving yet

IRIX stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 17 weeks. It is 19.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 17
Industry in uptrend: 27% -7 in 4 wk
Insider buys, 12 months: $761K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 29 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

20 Apr – 19 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months78

Sale orders, 12 months0

Buyers · sellers3 · 0

Who	Did	Shares	Traded
Romeo R. DizonChief Financial Officer	bought	7,900at $0.63	16 Sep 2026filed 16 Sep 2026
Romeo R. DizonChief Financial Officer	bought	2,354at $0.65	14 Sep 2026filed 14 Sep 2026
Romeo R. DizonChief Financial Officer	bought	5,100at $0.68	10 Sep 2026filed 10 Sep 2026
Romeo R. DizonChief Financial Officer	bought	1,300at $0.7488	24 Aug 2026filed 24 Aug 2026
Romeo R. DizonChief Financial Officer	bought	5,368at $0.7499	24 Aug 2026filed 24 Aug 2026
Romeo R. DizonChief Financial Officer	bought	975at $1.14	12 Jun 2026filed 15 Jun 2026
Romeo R. DizonChief Financial Officer	bought	1,675at $1.14	11 Jun 2026filed 12 Jun 2026
Romeo R. DizonChief Financial Officer	bought	2,400at $1.12	8 Jun 2026filed 9 Jun 2026
Romeo R. DizonChief Financial Officer	bought	2,521at $1.15	5 Jun 2026filed 8 Jun 2026
Romeo R. DizonChief Financial Officer	bought	2,400at $1.17	3 Jun 2026filed 3 Jun 2026
Romeo R. DizonChief Financial Officer	bought	5,004at $1.00	26 May 2026filed 26 May 2026
Shih-Yao David Lin10% owner	bought	7,371at $0.99	30 Mar 2026filed 7 Oct 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders29+4 on the quarter

New · exited7 · 3

Reported value$2.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026	514,593$589K	00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026	423,542$485K	+26,915+6.8%
MORGAN STANLEYnew · filed 13 Aug 2026	305,193$349K	+305,193
WEBER CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	180,451$207K	-79,107−30.5%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	138,960$159K	-21,199−13.2%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	98,950$113K	+38,099+62.6%
PERKINS CAPITAL MANAGEMENT INCadded · filed 24 Jul 2026	70,800$81K	+15,500+28.0%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	60,155$69K	00.0%
STATE STREET CORPunchanged · filed 7 Aug 2026	44,718$51K	00.0%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	40,454$46K	+2,833+7.5%